Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
-
New hope for Hard-to-Treat cancers: drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests the safety of combining two drugs, NEROFE and doxorubicin, in people with advanced solid tumors that have a KRAS mutation and express ST2. The main goal is to find the best dose and schedule. About 24 participants will receive weekly infusions of both…
Phase: PHASE1 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New drug combo aims to shrink Hard-to-Treat cervical tumors
Disease control Recruiting nowThis study tests whether combining two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with advanced cervical cancer that has stopped responding to initial treatment. The goal is to see if this combination can boost the immune system's ability to fight the cancer…
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New tool helps black and latina women decide on breast MRI
Knowledge-focused Recruiting nowThis study tests whether a decision-support tool helps high-risk Black and Latina women make informed choices about getting a breast MRI. About 80 women will either receive standard care or extra guidance to help them decide. The goal is to see if the tool improves knowledge and …
Phase: NA • Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC